Innovasis Provides Business Update
SALT LAKE CITY, June 26, 2018 – Innovasis provided a business update related to recent organizational milestones.
Leadership Team Expansion
Innovasis is pleased to announce the recent expansion of their leadership team. Mike Wheelock was hired as Vice President of Sales and David Oka as Director of Business Development and Clinical Affairs.
“The addition of experienced industry veterans like David and Mike ensures Innovasis continues developing world-class distribution and supports our commitment to collect compelling clinical evidence for our evolving HA PEEK enhanced interbody platform,” said Innovasis President Mike English. “We are excited and honored to have them join our rapidly expanding team.”
Headquarters Groundbreaking
With continued company growth, Innovasis is excited to announce the groundbreaking of new headquarters in Salt Lake City, Utah. The 50,000 sq. ft. facility will include a two-station cadaver lab, in house manufacturing, and corporate offices.
“This move will allow us to train our surgeon and distribution partners in an extraordinary setting, expand our manufacturing capabilities, and create operational efficiencies crucial to remain competitive in this market,” commented English.
36th Humanitarian Trip Completed
Innovasis completed their 36th humanitarian trip to Lima, Peru. This is the second humanitarian trip the company has completed in 2018. “Our humanitarian mission the past six years includes a total of total of 60 surgeon participants and over 200 spine and cranial cases completed. We are grateful for the expert staff, surgeons, and nurses that make it possible for Innovasis to continue improving patient healthcare in Peru,” said English.
About Innovasis
Innovasis is a groundbreaking company engaged in the research, development, manufacturing, and marketing of spinal implant devices and related products. Innovasis offers a spinal product line with implants and instruments that address the major pathologies and focus areas of traditional spinal surgery.